The Saudi Arabia total parenteral nutrition market size was estimated at USD 99.82 million in 2025 to reach nearly USD 105.61 million by 2035, and is expanding at a CAGR of 5.8% from 2026 to 2035. The rising prevalence of chronic diseases is driving the demand for total parenteral nutrition.

Total parenteral nutrition (TPN) is a medical treatment used to manage and treat malnutrition. It falls under the category of nutritional medications and is indicated when there are impaired gastrointestinal function or contraindications to enteral nutrition. TPN involves administering nutrition intravenously when it is the only source of nutrition the patient is receiving.

The growth of the TPN market is primarily driven by the increasing prevalence of chronic diseases and premature births, alongside expanding healthcare infrastructure and health system reforms that enhance access to parenteral nutrition solutions. There is an increasing demand for TPN within the broader market for intravenous solutions. Riyadh serves as a hub for advanced hospitals and multidisciplinary nutrition teams, while Jeddah and Dammam benefit from healthcare needs related to pilgrimage and the development of growing health clusters, contributing to overall market expansion.

Saudi Arabia Total Parenteral Nutrition Market Share, By Product, 2025, (%)

• Premix TPN (internal compounding) - Premix TPN (internal compounding) leads the product segment, with a 43% share, driven by efficiency and decreased preparation time in healthcare settings.
• Premix TPN (direct use) - Premix TPN (direct use) holds a 22% share in the market, due to reduced risk of contamination, improved sterility, and convenience.
• Compounded TPN (in-house) - Compounded TPN (in-house) accounts for a 20% share, driven by customization demands within hospitals.
• Compounded TPN (third-party) - Compounded TPN (third-party) captures a 15% share, driven by the rising trend of outsourcing TPN preparation.

Saudi Arabia Total Parenteral Nutrition Market Share, By Packaging Volume, 2025, (%)

• >1 L - Packaging volumes greater than 1 L lead the segment, with a 47% share, because of strong demand for adult patient treatments.
• 500 mL - 500 mL packaging holds a 23% share, balancing dosage requirements and storage efficiency, and its versatility and widespread usage.
• 250 mL - 250 mL packaging accounts for an 18% share, commonly used for controlled or moderate nutrition needs and is preferred in home healthcare settings for their portability and ease of handling.
• <100 mL - Packaging below 100 mL represents a 12% share, mainly used for pediatric and neonatal applications.

Saudi Arabia Total Parenteral Nutrition Market Share, By Customer, 2025, (%)

• B2G - B2G leads the customer segment, holds a 56% share, due to government procurement and public healthcare systems.
• B2B - B2B holds a 30% share, supported by growing patients in private hospitals and healthcare providers.
• B2C - B2C accounts for a 14% share, centered on home care settings and rising direct patient access.

Saudi Arabia Total Parenteral Nutrition Market Share, By End Use, 2025, (%)

• Adult patients - Adult patients dominate the end-use segment, with a 72.5% share, due to the rising incidence of chronic diseases that need nutritional support.
• Pediatric & neonatal patients - Pediatric & neonatal patients account for a 27.5% share, due to growing demand for specialized nutritional requirements in early life stages.

Top Companies in the Saudi Arabia Total Parenteral Nutrition Market

• Ministry of National Guard Health Affairs (MNGHA) (King Abdulaziz Medical City-Jeddah)
• King Faisal Specialist Hospital and Research Center
• King Saud University Medical City
• King Salman Hospital
• Al Mouwasat
• Saudi Center for Total Parenteral Nutrition (SCTPN)
• Dr. Soliman Fakeeh Hospital, Jeddah
• Armed Forces Hospital Southern Region

Segments Covered in the Report

By Product

• Premix TPN bags used by hospitals for internal compounding
• Premix TPN bags used directly by hospitals
• Compounded TPN bags prepared in-house by hospitals
• Compounded TPN bags supplied to hospitals by third-party manufacturers

By Packaging Volume

• >1 L
• 500 mL
• 250 mL
• <100 mL

By Customer

• B2G
• B2B
• B2C

By End Use

• Adult Patients
• Pediatric & Neonatal Patients